Tau Protein Phosphorylated at Threonine 181 in CSF as a Neurochemical Biomarker in Alzheimer's Disease: Original Data and Review of the Literature

By Lewczuk Piotr   Esselmann Hermann   Bibl Mirko   Beck Georg   Maler Juan Manuel   Otto Markus   Kornhuber Johannes   Wiltfang Jens  

Journal of Molecular Neuroscience, Vol. 23, Iss. 1-2, 2004-04 ,pp. : 115-122

Humana Press, Inc

Access to resources Recommend Favorite

Tau Neurofibrillary Pathology and Microtubule Stability

By Michaelis Mary L.   Dobrowsky Rick T.   Li Guibin  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 289-294

Humana Press, Inc

Access to resources Recommend Favorite

CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study

By Arai H.   Ishiguro K.   Ohno H.   Moriyama M.   Itoh N.   Okamura N.   Matsui T.   Morikawa Y.-i.   Horikawa E.   Kohno H.   Sasaki H.   Imahori K.  

Experimental Neurology, Vol. 166, Iss. 1, 2000-11 ,pp. : 201-203

Elsevier

Access to resources Recommend Favorite

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

By Braak Heiko   Alafuzoff Irina   Arzberger Thomas   Kretzschmar Hans   Tredici Kelly  

Acta Neuropathologica, Vol. 112, Iss. 4, 2006-10 ,pp. : 389-404

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies

By  

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 217-228

Bentham Science Publishers

Access to resources Recommend Favorite